Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Staudt

Showing results (381-390 of 434) with videos related to

Pageof 44
Sort By:
The Journal of Clinical Investigation|May 2, 2024
BTK drives neutrophil activation for sterilizing antifungal immunityJigar V Desai, Marissa A Zarakas, Andrew L Wishart, et al.
Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.
The American Journal of Pathology|June 25, 2004
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphomaJaveed Iqbal, Warren G Sanger, Douglas E Horsman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOPXin Huang, Bin Meng, Javeed Iqbal, et al.
Nature|February 17, 2000
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingA A Alizadeh, M B Eisen, R E Davis, et al.
The Journal of Experimental Medicine|September 29, 2023
TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell toleranceElif Çakan, Marie Dominique Ah Kioon, Yolanda Garcia-Carmona, et al.
Nature Medicine|July 21, 2015
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphomaWyndham H Wilson, Ryan M Young, Roland Schmitz, et al.
Blood|September 21, 2013
EZH2 mutations are frequent and represent an early event in follicular lymphomaCsaba Bödör, Vera Grossmann, Nikolay Popov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded BiopsiesDavid W Scott, Pau Abrisqueta, George W Wright, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Pageof 44

Showing results (381-390 of 434) with videos related to

Sort By:
Pageof 44
The Journal of Clinical Investigation|May 2, 2024
BTK drives neutrophil activation for sterilizing antifungal immunityJigar V Desai, Marissa A Zarakas, Andrew L Wishart, et al.
Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.
The American Journal of Pathology|June 25, 2004
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphomaJaveed Iqbal, Warren G Sanger, Douglas E Horsman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOPXin Huang, Bin Meng, Javeed Iqbal, et al.
Nature|February 17, 2000
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingA A Alizadeh, M B Eisen, R E Davis, et al.
The Journal of Experimental Medicine|September 29, 2023
TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell toleranceElif Çakan, Marie Dominique Ah Kioon, Yolanda Garcia-Carmona, et al.
Nature Medicine|July 21, 2015
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphomaWyndham H Wilson, Ryan M Young, Roland Schmitz, et al.
Blood|September 21, 2013
EZH2 mutations are frequent and represent an early event in follicular lymphomaCsaba Bödör, Vera Grossmann, Nikolay Popov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded BiopsiesDavid W Scott, Pau Abrisqueta, George W Wright, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Pageof 44